A longevity science panel featuring Aubrey de Grey, David Sinclair, Joao Pedro de Magalhaes, Liz Parrish, Jean Hebert, Alexandra Stolzing, Greg Fahy, and David Gobel.
Sebastian Brunemeier is a geroscientist, biotech founder, and venture capitalist. He was formerly Principal at Apollo Health Ventures, one of the largest aging-focussed VC firms in the world. Sebastian was co-founder of Samsara Therapeutics, Cyclone...
Marinna Madrid is a co-founder of Cellino, a startup that leverages AI, robotics, and laser-editing to develop and manufacture stem cell therapies at scale. She obtained her Ph.D in Physics from Harvard and was named a Forbes Top 30 under 30 in...
Tyler Golato is one of the masterminds behind VitaDAO, a decentralized organization that aims to fund and commercialize longevity research -- all on the Ethereum blockchain.
Marco Quarta is the co-founder and CEO of Rubedo Life Science, a startup that develops drugs that target aging. Their lead program is a senolytic prodrug that targets senescent cells in a targeted manner.
Matt Scholz is a co-founder of Oisin Biotechnologies, a longevity startup that is developing a proteome-lipid nanoparticle gene therapy platform. Their lead program is a senolytic gene therapy to target senescent cells.
Kristen Fortney is the CEO and co-founder of BioAge Labs, a startup that leverages artificial intelligence and machine learning to find anti-aging drugs.
Jean Hebert is a professor of neurogenetics at the Albert Einstein College of Medicine and author of the book "Replacing Aging". He is currently developing an approach to reverse aging in the brain by progressive replacement of neural tissue.
Yuva Biosciences is an early stage biotech company attempting to reverse aging by targeting mitochondrial dysfunction.
Maximon is a Swiss longevity venture building company. They partner with entrepreneurs to build longevity-focussed companies from scratch.